EMBO Rep. 2023 Mar 02. e56932
Shumeng Hao,
Sulin Zhang,
Jialin Ye,
Lifan Chen,
Yan Wang,
Siyu Pei,
Qingchen Zhu,
Jing Xu,
Yongzhen Tao,
Neng Zhou,
Huiyong Yin,
Cai-Wen Duan,
Chaoming Mao,
Mingyue Zheng,
Yichuan Xiao.
Obesity is associated with metabolic disorders and chronic inflammation. However, the obesity-associated metabolic contribution to inflammatory induction remains elusive. Here, we show that, compared with lean mice, CD4+ T cells from obese mice exhibit elevated basal levels of fatty acid β-oxidation (FAO), which promote T cell glycolysis and thus hyperactivation, leading to enhanced induction of inflammation. Mechanistically, the FAO rate-limiting enzyme carnitine palmitoyltransferase 1a (Cpt1a) stabilizes the mitochondrial E3 ubiquitin ligase Goliath, which mediates deubiquitination of calcineurin and thus enhances activation of NF-AT signaling, thereby promoting glycolysis and hyperactivation of CD4+ T cells in obesity. We also report the specific GOLIATH inhibitor DC-Gonib32, which blocks this FAO-glycolysis metabolic axis in CD4+ T cells of obese mice and reduces the induction of inflammation. Overall, these findings establish a role of a Goliath-bridged FAO-glycolysis axis in mediating CD4+ T cell hyperactivation and thus inflammation in obese mice.
Keywords: FAO; Goliath; glycolysis; inflammation; obesity